The (Epi)genetics of human synovial sarcoma

Genes Chromosomes and Cancer

Volumn 46, Issue 2, 2007, Pages 107-117

  De Bruijn, Diederik R M ^a   Nap, Jan Peter ^b   Van Kessel, Ad Geurts ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HANZE UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; NUCLEAR PROTEIN; PROTEIN SS18; PROTEIN SSX; REPRESSOR PROTEIN; SS18 SSX FUSION PROTEIN;

CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER THERAPY; CHEMOTHERAPY; CHROMATIN ASSEMBLY AND DISASSEMBLY; DISEASE COURSE; DNA MODIFICATION; EPIGENETICS; HUMAN; METASTASIS; MOLECULAR MECHANICS; MOLECULAR MODEL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RADIATION; REVIEW; SOFT TISSUE TUMOR; SYNOVIAL SARCOMA; TRANSCRIPTION REGULATION; TREATMENT PLANNING; TREATMENT RESPONSE;

EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; SARCOMA, SYNOVIAL; TRANSLOCATION, GENETIC;

EID: 33845484805     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20399     Document Type: Review

References (123)

1. Allander SV, Illei PB, Chen Y, Antonescu CR, Bittner M, Ladanyi M, Meltzer PS. 2002. Expression profiling of synovial sarcoma by cDNA microarrays: Association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol 161:1587-1595.
2. Andrassy RJ, Okcu MF, Despa S, Raney RB. 2001. Synovial sarcoma in children: Surgical lessons from a single institution and review of the literature. J Am Coll Surg 192:305-313.
3. Antonescu CR, Leung DH, Dudas M, Ladanyi M, Brennan M, Woodruff JM, Cordon-Cardo C. 2000. Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications. Am J Pathol 156:977-983.
4. Argani P, Zakowski MF, Klimstra DS, Rosai J, Ladanyi M. 1998. Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases. Mod Pathol 11:65-71.
5. Asada M, Irie K, Morimoto K, Yamada A, Ikeda W, Takeuchi M, Takai Y. 2003. ADIP, a novel Afadin- and α-actinin-binding protein localized at cell-cell adherens junctions. J Biol Chem 278:4103-4111.
6. Banine F, Bartlett C, Gunawardena R, Muchardt C, Yaniv M, Knudsen ES, Weissman BE, Sherman LS. 2005. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. Cancer Res 65:3542-3547.
7. Bannister AJ, Kouzarides T. 2005. Reversing histone methylation. Nature 436:1103-1106.
8. Begay-Muller V, Ansieau S, Leutz A. 2002. The LIM domain protein Lmo2 binds to AF6, a translocation partner of the MLL oncogene. FEBS Lett 521:36-38.
9. Bergh P, Meis-Kindblom JM, Gherlinzoni F, Berlin O, Bacchini P, Bertoni F, Gunterberg B, Kindblom LG. 1999. Synovial sarcoma: Identification of low and high risk groups. Cancer 85:2596-2607.
10. Billings SD, Walsh SV, Fisher C, Nusrat A, Weiss SW, Folpe AL. 2004. Aberrant expression of tight junction-related proteins ZO-1, claudin-1 and occludin in synovial sarcoma: An immunohistochemical study with ultrastructural correlation. Mod Pathol 17:141-149.
11. Bokemeyer C, Franzke A, Hartmann JT, Schober C, Arseniev L, Metzner B, Link H, Kanz L, Schmoll HJ. 1997. A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas. Cancer 80:1221-1227.
12. Brett D, Whitehouse S, Antonson P, Shipley J, Cooper C, Goodwin G. 1997. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies. Hum Mol Genet 6:1559-1564.
13. Cairns BR. 2005. Chromatin remodeling complexes: Strength in diversity, precision through specialization. Curr Opin Genet Dev 15:185-190.
14. Chaplin T, Bernard O, Beverloo HB, Saha V, Hagemeijer A, Berger R, Young BD. 1995. The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. Blood 86:2073-2076.
15. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AM, Gusterson BA, Cooper CS. 1994. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 7:502-508.
16. Clarkson P, Ferguson PC. 2004. Primary multidisciplinary management of extremity soft tissue sarcomas. Curr Treat Options Oncol 5:451-462.
17. Cosgrove MS, Boeke JD, Wolberger C. 2004. Regulated nucleosome mobility and the histone code. Nat Struct Mol Biol 11:1037-1043.
18. Crew AJ, Clark J, Fisher C, Gill S, Grimer R, Chand A, Shipley J, Gusterson BA, Cooper CS. 1995. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 14:2333-2340.
19. Daniel JA, Pray-Grant MG, Grant PA. 2005. Effector proteins for methylated histones: An expanding family. Cell Cycle 4:919-926.
20. de Bruijn DRH, Allander SV, van Dijk A, Willemse M, Thijssen J, van Groningen J, Meltzer P, Geurts van Kessel A. 2006b. The synovial sarcoma associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation. Cancer Res 66:9474-9482.
21. de Bruijn DRH, Baats E, Zechner U, de Leeuw B, Balemans M, Olde Weghuis D, Hirning-Folz U, Geurts van Kessel A. 1996. Isolation and characterization of the mouse homolog of SYT, a gene implicated in the development of human synovial sarcomas. Oncogene 13:643-648.
22. de Bruijn DRH, dos Santos NR, Kater-Baats E, Thijssen J, van den Berk L, Stap J, Balemans M, Schepens M, Merkx G, Geurts van Kessel A. 2002. The cancer-related protein SSX2 interacts with the human homologue of a Ras-like GTPase interactor, RAB3IP, and a novel nuclear protein, SSX2IP. Genes Chromosomes Cancer 34:285-298.
23. de Bruijn DRH, dos Santos NR, Thijssen J, Balemans M, Debernardi S, Linder B, Young BD, Geurts van Kessel A. 2001b. The synovial sarcoma associated protein SYT interacts with the acute leukemia associated protein AF10. Oncogene 20:3281-3289.
24. de Bruijn DRH, Geurts van Kessel A. 2006a. Common origin of the human synovial sarcoma associated SS18 and SS18L1 gene loci. Cytogenet Genome Res 112:222-226.
25. de Bruijn DRH, Kater-Baats E, Eleveld M, Merkx G, Geurts Van Kessel A. 2001a. Mapping and characterization of the mouse and human SS18 genes, two human SS18-like genes and a mouse SS18 pseudogene. Cytogenet Cell Genet 92:310-319.
26. de Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A. 1995. Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2;q11.2)-positive synovial sarcomas. Hum Mol Genet 4:1097-1099.
27. de Leeuw B, Balemans M, Weghuis DO, Seruca R, Janz M, Geraghty MT, Gilgenkrantz S, Ropers HH, Geurts van Kessel A. 1994. Molecular cloning of the synovial sarcoma-specific translocation (X;18)(p11.2;q11.2) breakpoint. Hum Mol Genet 3:745-749.
28. de Leeuw B, Berger W, Sinke RJ, Suijkerbuijk RF, Gilgenkrantz S, Geraghty MT, Valle D, Monaco AP, Lehrach H, Ropers HH, Geurts van Kessel A. 1993a. Identification of a yeast artificial chromosome (YAC) spanning the synovial sarcoma-specific t(X;18)(p11.2;q11.2) breakpoint. Genes Chromosomes Cancer 6:182-189.
29. de Leeuw B, Suijkerbuijk RF, Balemans M, Sinke RJ, de Jong B, Molenaar WM, Meloni AM, Sandberg AA, Geraghty M, Hofker M, Ropers HH, Geurts van Kessel A. 1993b. Sublocalization of the synovial sarcoma-associated t(X;18) chromosomal breakpoint in Xp11.2 using cosmid cloning and fluorescence in situ hybridization. Oncogene 8:1457-1463.
30. Debernardi S, Bassini A, Jones LK, Chaplin T, Linder B, de Bruijn DR, Meese E, Young BD. 2002. The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex. Blood 99:275-281.
31. Deplus R, Brenner C, Burgers WA, Putmans P, Kouzarides T, de Launoit Y, Fuks F. 2002. Dnmt3L is a transcriptional repressor that recruits histone deacetylase. Nucleic Acids Res 30:3831-3838.
32. dos Santos NR, de Bruijn DR, Balemans M, Janssen B, Gartner F, Lopes JM, de Leeuw B, Geurts van Kessel A. 1997. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins. Hum Mol Genet 6:1549-1558.
33. dos Santos NR, de Bruijn DR, Geurts van Kessel A. 2001. Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer 30:1-14.
34. dos Santos NR, de Bruijn DR, Kater-Baats E, Otte AP, Geurts van Kessel A. 2000. Delineation of the protein domains responsible for SYT, SSX, and SYT-SSX nuclear localization. Exp Cell Res 256:192-202.
35. Eid JE, Kung AL, Scully R, Livingston DM. 2000. p300 interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion. Cell 102:839-848.
36. Esteller M. 2006. CpG island methylation and histone modifications: Biology and clinical significance. Ernst Schering Res Found Workshop 57:115-126.
37. Ferrari A, Gronchi A, Casanova M, Meazza C, Gandola L, Collini P, Lozza L, Bertulli R, Olmi P, Casali PG. 2004. Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 101:627-634.
38. Fuks F, Burgers WA, Godin N, Kasai M, Kouzarides T. 2001. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J 20:2536-2544.
39. Garrett-Engele CM, Siegal ML, Manoli DS, Williams BC, Li H, Baker BS. 2002. Intersex, a gene required for female sexual development in Drosophila, is expressed in both sexes and functions together with doublesex to regulate terminal differentiation. Development 129:4661-4675.
40. Guillou L, Benhattar J, Bonichon F, Gallagher G, Terrier P, Stauffer E, Somerhausen Nde S, Michels JJ, Jundt G, Vince DR, Taylor S, Genevay M, Collin F, Trassard M, Coindre JM. 2004. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: A multicenter, retrospective analysis. J Clin Oncol 22:4040-4050.
41. Gustafson P. 1994. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl 259:1-31.
42. Harikrishnan KN, Chow MZ, Baker EK, Pal S, Bassal S, Brasacchio D, Wang L, Craig JM, Jones PL, Sif S, El-Osta A. 2005. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet 37:254-264.
43. Hiraga H, Nojima T, Abe S, Sawa H, Yamashiro K, Yamawaki S, Kaneda K, Nagashima K. 1998. Diagnosis of synovial sarcoma with the reverse transcriptase-polymerase chain reaction: Analyses of 84 soft tissue and bone tumors. Diagn Mol Pathol 7:102-110.
44. Holmgren C, Kanduri C, Dell G, Ward A, Mukhopadhya R, Kanduri M, Lobanenkov V, Ohlsson R. 2001. CpG methylation regulates the Igf2/H19 insulator. Curr Biol 11:1128-1130.
45. Howard PW, Maurer RA. 2000. Identification of a conserved protein that interacts with specific LIM homeodomain transcription factors. J Biol Chem 275:13336-13342.
46. Inagaki H, Murase T, Otsuka T, Eimoto T. 1999. Detection of SYT-SSX fusion transcript in synovial sarcoma using archival cytologic specimens. Am J Clin Pathol 111:528-533.
47. Ishida M, Tanaka S, Ohki M, Ohta T. 2004. Transcriptional co-activator activity of SYT is negatively regulated by BRM and Brg1. Genes Cells 9:419-428.
48. Ito T, Ouchida M, Ito S, Jitsumori Y, Morimoto Y, Ozaki T, Kawai A, Inoue H, Shimizu K. 2004. SYT, a partner of SYT-SSX oncoprotein in synovial sarcomas, interacts with mSin3A, a component of histone deacetylase complex. Lab Invest 84:1484-1490.
49. Ito T, Ouchida M, Morimoto Y, Yoshida A, Jitsumori Y, Ozaki T, Sonobe H, Inoue H, Shimizu K. 2005. Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo. Cancer Lett 224:311-319.
50. Iwasaki T, Koibuchi N, Chin WW. 2005. Synovial sarcoma translocation (SYT) encodes a nuclear receptor coactivator. Endocrinology 146:3892-3899.
51. Johnson CN, Adkins NL, Georgel P. 2005. Chromatin remodeling complexes: ATP-dependent machines in action. Biochem Cell Biol 83:405-417.
52. Kampe CE, Rosen G, Eilber F, Eckardt J, Lowenbraun S, Foster J, Forscher C, Selch M. 1993. Synovial sarcoma. A study of intensive chemotherapy in 14 patients with localized disease. Cancer 72:2161-2169.
53. Kato H, Tjernberg A, Zhang W, Krutchinsky AN, An W, Takeuchi T, Ohtsuki Y, Sugano S, de Bruijn DR, Chait BT, Roeder RG. 2002. SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones. J Biol Chem 277:5498-5505.
54. Kawamata N, Sakajiri S, Sugimoto KJ, Isobe Y, Kobayashi H, Oshimi K. 2002. A novel chromosomal translocation t(1;14)(q25;q32) in pre-B acute lymphoblastic leukemia involves the LIM homeodomain protein gene, Lhx4. Oncogene 21:4983-4991.
55. Kawauchi S, Goto Y, Ihara K, Furuya T, Oga A, Tsuneyoshi M, Kawai S, Sasaki K. 2002. Survival analysis with p27 expression and apoptosis appears to estimate the prognosis of patients with synovial sarcoma more accurately. Cancer 94:2712-2718.
56. Kuriyama M, Harada N, Kuroda S, Yamamoto T, Nakafuku M, Iwamatsu A, Yamamoto D, Prasad R, Croce C, Canaani E, Kaibuchi K. 1996. Identification of AF-6 and canoe as putative targets for Ras. J Biol Chem 271:607-610.
57. Kwon H, Imbalzano AN, Khavari PA, Kingston RE, Green MR. 1994. Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex. Nature 370:477-481.
58. Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldsmith JD, Brooks JS, Goldblum JR, Ali SZ, Shipley J, Cooper CS, Fisher C, Skytting B, Larsson O. 2002. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: A multi-institutional retrospective study of 243 patients. Cancer Res 62:135-140.
59. Lasota J, Jasinski M, Debiec-Rychter M, Szadowska A, Limon J, Miettinen M. 1998. Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: a reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma. Mod Pathol 11:626-633.
60. LaVoie HA. 2005. Epigenetic control of ovarian function: The emerging role of histone modifications. Mol Cell Endocrinol 243:12-18.
61. Lee YF, John M, Edwards S, Clark J, Flohr P, Maillard K, Edema M, Baker L, Mangham DC, Grimer R, Wooster R, Thomas JM, Fisher C, Judson I, Cooper CS. 2003. Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling. Br J Cancer 88:510-515.
62. Li S, Armstrong CM, Bertin N, Ge H, Milstein S, Boxem M, Vidalain PO, Han JD, Chesneau A, Hao T, Goldberg DS, Li N, Martinez M, Rual JF, Lamesch P, Xu L, Tewari M, Wong SL, Zhang LV, Berriz GF, Jacotot L, Vaglio P, Reboul J, Hirozane-Kishikawa T, Vidal M. 2004. A map of the interactome network of the metazoan C. elegans. Science 303:540-543.
63. Lim FL, Soulez M, Koczan D, Thiesen HJ, Knight JC. 1998. A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene 17:2013-2018.
64. Linder B, Newman R, Jones LK, Debernardi S, Young BD, Freemont P, Verrijzer CP, Saha V. 2000. Biochemical analyses of the AF10 protein: The extended LAP/PHD-finger mediates oligomerisation. J Mol Biol 299:369-378.
65. Lopes JM, Hannisdal E, Bjerkehagen B, Bruland OS, Danielsen HE, Pettersen EO, Sobrinho-Simoes M, Nesland JM. 1998. Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers. Anal Cell Pathol 16:45-62.
66. Machen SK, Easley KA, Goldblum JR. 1999. Synovial sarcoma of the extremities: A clinicopathologic study of 34 cases, including semi-quantitative analysis of spindled, epithelial, and poorly differentiated areas. Am J Surg Pathol 23:268-275.
67. Machinis K, Pantel J, Netchine I, Leger J, Camand OJ, Sobrier ML, Dastot-Le Moal F, Duquesnoy P, Abitbol M, Czernichow P, Amselem S. 2001. Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 69:961-968.
68. Margolin JF, Friedman JR, Meyer WK, Vissing H, Thiesen HJ, Rauscher FJ, III. 1994. Kruppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci USA 91:4509-4513.
69. Mezzelani A, Dagrada GP, Sozzi G, Pierotti MA, Pilotti S. 2000. SYT-SSX fusion transcripts and epithelial differentiation in synovial sarcoma. Diagn Mol Pathol 9:234, 235.
70. Mitchell PJ, Tjian R. 1989. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245:371-378.
71. Morimoto Y, Ouchida M, Ozaki T, Kawai A, Ito T, Yoshida A, Inoue H, Shimizu K. 2003. Splicing isoform of SYT-SSX fusion protein accelerates transcriptional activity and cell proliferation. Cancer Lett 199:35-43.
72. Mullen JR, Zagars GK. 1994. Synovial sarcoma outcome following conservation surgery and radiotherapy. Radiother Oncol 33:23-30.
73. Nilsson G, Wang M, Wejde J, Kanter L, Karlen J, Tani E, Kreicbergs A, Larsson O. 1998. Reverse transcriptase polymerase chain reaction on fine needle aspirates for rapid detection of translocations in synovial sarcoma. Acta Cytol 42:1317-1324.
74. Oda Y, Hashimoto H, Takeshita S, Tsuneyoshi M. 1993b. The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma. Cancer 72:478-485.
75. Oda Y, Hashimoto H, Tsuneyoshi M, Takeshita S. 1993a. Survival in synovial sarcoma. A multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival. Am J Surg Pathol 17:35-44.
76. Oda Y, Sakamoto A, Saito T, Kinukawa N, Iwamoto Y, Tsuneyoshi M. 2000. Expression of hepatocyte growth factor (HGF)/scatter factor and its receptor c-MET correlates with poor prognosis in synovial sarcoma. Hum Pathol 31:185-192.
77. Okcu MF, Munsell M, Treuner J, Mattke A, Pappo A, Cain A, Ferrari A, Casanova M, Ozkan A, Raney B. 2003. Synovial sarcoma of childhood and adolescence: A multicenter, multivariate analysis of outcome. J Clin Oncol 21:1602-1611.
78. Owen DJ, Ornaghi P, Yang JC, Lowe N, Evans PR, Ballario P, Neuhaus D, Filetici P, Travers AA. 2000. The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase EMBO J 19:6141-6149.
79. Panagopoulos I, Mertens F, Isaksson M, Limon J, Gustafson P, Skytting B, Akerman M, Sciot R, Dal Cin P, Samson I, Iliszko M, Ryoe J, Debiec-Rychter M, Szadowska A, Brosjo O, Larsson O, Rydholm A, Mandahl N. 2001. Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer 31:362-372.
80. Park SJ, Kim HK, Kim CK, Park SK, Go ES, Kim ME, Hong DS. 2004. A case of renal synovial sarcoma: Complete remission was induced by chemotherapy with doxorubicin and ifosfamide. Korean J Intern Med 19:62-65.
81. Perani M, Antonson P, Hamoudi R, Ingram CJ, Cooper CS, Garrett MD, Goodwin GH. 2005. The proto-oncoprotein SYT interacts with SYT-interacting protein/co-activator activator (SIP/CoAA), a human nuclear receptor co-activator with similarity to EWS and TLS/FUS family of proteins. J Biol Chem 280:42863-42876.
82. Perani M, Ingram CJ, Cooper CS, Garrett MD, Goodwin GH. 2003. Conserved SNH domain of the proto-oncoprotein SYT interacts with components of the human chromatin remodelling complexes, while the QPGY repeat domain forms homo-oligomers. Oncogene 22:8156-8167.
83. Perrin L, Bloyer S, Ferraz C, Agrawal N, Sinha P, Dura JM. 2003. The leucine zipper motif of the Drosophila AF10 homologue can inhibit PRE-mediated repression: Implications for leukemogenic activity of human MLL-AF10 fusions. Mol Cell Biol 23:119-130.
84. Poteat HT, Corson JM, Fletcher JA. 1995. Detection of chromosome 18 rearrangement in synovial sarcoma by fluorescence in situ hybridization. Cancer Genet Cytogenet 84:76-81.
85. Prasad R, Gu Y, Alder H, Nakamura T, Canaani O, Saito H, Huebner K, Gale RP, Nowell PC, Kuriyama K, Miyazaki Y, Croce CM, Canaani E. 1993. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res 53:5624-5628.
86. Raetzman LT, Ward R, Camper SA. 2002. Lhx4 and Prop1 are required for cell survival and expansion of the pituitary primordia. Development 129:4229-4239.
87. Raney RB. 2005. Synovial sarcoma in young people: Background, prognostic factors, and therapeutic questions. J Pediatr Hematol Oncol 27:207-211.
88. Rosen G, Forscher C, Lowenbraun S, Eilber F, Eckardt J, Holmes C, Fu YS. 1994. Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. Cancer 73:2506-2511.
89. Saito T, Oda Y, Sakamoto A, Tamiya S, Kinukawa N, Hayashi K, Iwamoto Y, Tsuneyoshi M. 2000. Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of β-catenin mutations in synovial sarcoma. J Pathol 192:342-350.
90. Sandberg AA, Bridge JA. 2002. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma. Cancer Genet Cytogenet 133:1-23.
91. Satijn DP, Otte AP. 1999. Polycomb group protein complexes: Do different complexes regulate distinct target genes? Biochim Biophys Acta 1447:1-16.
92. Shao Z, Raible F, Mollaaghababa R, Guyon JR, Wu CT, Bender W, Kingston RE. 1999. Stabilization of chromatin structure by PRC1, a Polycomb complex. Cell 98:37-46.
93. Sheng HZ, Moriyama K, Yamashita T, Li H, Potter SS, Mahon KA, Westphal H. 1997. Multistep control of pituitary organogenesis. Science 278:1809-1812.
94. Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM. 1996. Synovial sarcoma: Prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol 14:1201-1208.
95. Skytting BT, Bauer HC, Perfekt R, Huuhtanen R, Alvegard TA, Berlin O, Gustafson P, Klepp R, Lofvenberg R, Saeter G, Trovik CS, Wahlstrom O. 1999a. Clinical course in synovial sarcoma: A Scandinavian sarcoma group study of 104 patients. Acta Orthop Scand 70:536-542.
96. Skytting BT, Bauer HC, Perfekt R, Nilsson G, Larsson O. 1999b. Ki-67 is strongly prognostic in synovial sarcoma: Analysis based on 86 patients from the Scandinavian sarcoma group register. Br J Cancer 80:1809-1814.
97. Skytting B, Nilsson G, Brodin B, Xie Y, Lundeberg J, Uhlen M, Larsson O. 1999c. A novel fusion gene, SYT-SSX4, in synovial sarcoma. J Natl Cancer Inst 91:974-975.
98. Soulez M, Saurin AJ, Freemont PS, Knight JC. 1999. SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex. Oncogene 18:2739-2746.
99. Spillane AJ, A'Hern R, Judson IR, Fisher C, Thomas JM. 2000. Synovial sarcoma: A clinicopathologic, staging, and prognostic assessment. J Clin Oncol 18:3794-3803.
100. Spurrell EL, Fisher C, Thomas JM, Judson IR. 2005. Prognostic factors in advanced synovial sarcoma: An analysis of 104 patients treated at the Royal Marsden Hospital. Ann Oncol 16:437-444.
101. Storlazzi CT, Mertens F, Mandahl N, Gisselsson D, Isaksson M, Gustafson P, Domanski HA, Panagopoulos I. 2003. A novel fusion gene, SS18L1/SSX1, in synovial sarcoma. Genes Chromosomes Cancer 37:195-200.
102. Strobeck MW, DeCristofaro MF, Banine F, Weissman BE, Sherman LS, Knudsen ES. 2001. The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression. J Biol Chem 276:9273-9278.
103. Tamborini E, Agus V, Mezzelani A, Riva C, Sozzi G, Azzarelli A, Pierotti MA, Pilotti S. 2001. Identification of a novel spliced variant of the SYT gene expressed in normal tissues and in synovial sarcoma. Br J Cancer 84:1087-1094.
104. Thaete C, Brett D, Monaghan P, Whitehouse S, Rennie G, Rayner E, Cooper CS, Goodwin G. 1999. Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and colocalization with the SNF protein BRM in the nucleus. Hum Mol Genet 8:585-591.
105. Thompson RC, Jr., Garg A, Goswitz J, Cheng EY, Clohisy DR, Dusenbery K. 2000. Synovial sarcoma. Large size predicts poor outcome. Clin Orthop 373:18-24.
106. Toth K, Brun N, Langowski J. 2006. Chromatin compaction at the mononucleosome level. Biochemistry 45:1591-1598.
107. Trassard M, Le Doussal V, Hacene K, Terrier P, Ranchere D, Guillou L, Fiche M, Collin F, Vilain MO, Bertrand G, Jacquemier J, Sastre-Garau X, Bui NB, Bonichon F, Coindre JM. 2001. Prognostic factors in localized primary synovial sarcoma: A multicenter study of 128 adult patients. J Clin Oncol 19:525-534.
108. Tsuji S, Hisaoka M, Morimitsu Y, Hashimoto H, Shimajiri S, Komiya S, Ushijima M, Nakamura T. 1998. Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Am J Pathol 153:1807-1812.
109. van de Rijn M, Barr FG, Collins MH, Xiong QB, Fisher C. 1999. Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma. Am J Clin Pathol 112:43-49.
110. van der Heide HJ, Veth RP, Pruszczynski M, Wobbes T, van Hoesel QG, Lemmens JA. 1998. Synovial sarcoma: Oncological and functional results. Eur J Surg Oncol 24:114-119.
111. van Glabbeke M, van Oosterom AT, Oosterhuis JW, Mouridsen H, Crowther D, Somers R, Verweij J, Santoro A, Buesa J, Tursz T. 1999. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: An analysis of 2, 185 patients treated with anthracycline-concaining first-line regimens-A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol 17:150-157.
112. Wei Y, Wang J, Zhu X, Shi D, Hisaoka M, Hashimoto H. 2002. Detection of SYT-SSX fusion transcripts in paraffin-embedded tissues of synovial sarcoma by reverse transcription-polymerase chain reaction. Chin Med J (Engl) 115:1043-1047.
113. Willeke F, Mechtersheimer G, Schwarzbach M, Weitz J, Zimmer D, Lehnert T, Herfarth C, von Knebel Doeberitz M. 1998. Detection of SYT-SSX1/2 fusion transcripts by reverse transcriptase-polymerase chain reaction (RT-PCR) is a valuable diagnostic tool in synovial sarcoma. Eur J Cancer 34:2087-2093.
114. Xie Y, Skytting B, Nilsson G, Brodin B, Larsson O. 1999. Expression of insulin-like growth factor-1 receptor in synovial sarcoma: Association with an aggressive phenotype. Cancer Res 59:3588-3591.
115. Xie Y, Skytting B, Nilsson G, Gasbarri A, Haslam K, Bartolazzi A, Brodin B, Mandahl N, Larsson O. 2002a. SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: A gain of function of the t(X;18)(p11.2;q11.2) translocation. Cancer Res 62:3861-3867.
116. Xie Y, Skytting B, Nilsson G, Grimer RJ, Mangham CD, Fisher C, Shipley J, Bjerkehagen B, Myklebost O, Larsson O. 2002b. The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2;q11.2) and the cell cycle machinery. Oncogene 21:5791-5796.
117. Yamaguchi M, Yamamoto K, Miura O. 2003. Aberrant expression of the LHX4 LIM-homeobox gene caused by t(1;14)(q25;q32) in chronic myelogenous leukemia in biphenotypic blast crisis. Genes Chromosomes Cancer 38:269-273.
118. Yamamoto T, Harada N, Kano K, Taya S, Canaani E, Matsuura Y, Mizoguchi A, Ide C, Kaibuchi K. 1997. The Ras target AF-6 interacts with ZO-1 and serves as a peripheral component of tight junctions in epithelial cells. J Cell Biol 139:785-795.
119. Yamashita T, Moriyama K, Sheng HZ, Westphal H. 1997. Lhx4, a LIM homeobox gene. Genomics 44:144-146.
120. Yan P, Muhlethaler A, Bourloud KB, Beck MN, Gross N. 2003. Hypermethylation-mediated regulation of CD44 gene expression in human neuroblastoma. Genes Chromosomes Cancer 36:129-138.
121. Yang P, Hirose T, Hasegawa T, Hizawa K, Sano T. 1998. Dual-colour fluorescence in situ hybridization analysis of synovial sarcoma. J Pathol 184:7-13.
122. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, Evans HL. 2003. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: An analysis of 225 patients. Cancer 97:2530-2543.
123. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D. 1999. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 13:1924-1935.